PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.66%
Revenue growth similar to AVGO's 6.54%. Walter Schloss would see if both companies share industry tailwinds.
6.29%
Gross profit growth at 50-75% of AVGO's 8.99%. Martin Whitman would question if cost structure or brand is lagging.
8.23%
EBIT growth below 50% of AVGO's 1460.00%. Michael Burry would suspect deeper competitive or cost structure issues.
8.57%
Operating income growth under 50% of AVGO's 1460.00%. Michael Burry would be concerned about deeper cost or sales issues.
0.46%
Net income growth under 50% of AVGO's 280.95%. Michael Burry would suspect the firm is falling well behind a key competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.72%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.11%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.73%
Dividend growth of 0.73% while AVGO is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-29.07%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-13.10%
Negative FCF growth while AVGO is at 28.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
53.66%
10Y revenue/share CAGR above 1.5x AVGO's 12.36%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
48.77%
5Y revenue/share CAGR above 1.5x AVGO's 12.36%. David Dodd would look for consistent product or market expansions fueling outperformance.
17.46%
3Y revenue/share CAGR 1.25-1.5x AVGO's 12.36%. Bruce Berkowitz might see better product or regional expansions than the competitor.
133.79%
10Y OCF/share CAGR under 50% of AVGO's 1029.45%. Michael Burry would worry about a persistent underperformance in cash creation.
87.28%
Below 50% of AVGO's 1029.45%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
49.88%
3Y OCF/share CAGR under 50% of AVGO's 1029.45%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
106.89%
Below 50% of AVGO's 474.29%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
120.86%
Below 50% of AVGO's 474.29%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
49.13%
Below 50% of AVGO's 474.29%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
15.89%
Equity/share CAGR of 15.89% while AVGO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
13.63%
Equity/share CAGR of 13.63% while AVGO is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
1.63%
Equity/share CAGR of 1.63% while AVGO is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
463.52%
Dividend/share CAGR of 463.52% while AVGO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
378.03%
Dividend/share CAGR of 378.03% while AVGO is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
200.44%
3Y dividend/share CAGR of 200.44% while AVGO is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
19.50%
AR growth well above AVGO's 9.14%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.16%
Inventory growth well above AVGO's 2.47%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.07%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
1.59%
Under 50% of AVGO's 4.52%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
4.52%
We increase R&D while AVGO cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
3.16%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.